Staar Surgical (STAA) Cash from Financing Activities (2010 - 2026)
Staar Surgical's (STAA) quarterly Cash from Financing Activities came in at -$1.7 million in Q2 2026, down 78.59% YoY from -$7.9 million in Q2 2025, and down 3286.0% on a QoQ basis from -$50000.0 in Q1 2026.
Staar Surgical (STAA) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Staar Surgical (STAA) has 17 years of Cash from Financing Activities data on file, last reported at -$1.7 million in Q2 2026.
- Quarterly Cash from Financing Activities fell 78.59% year-over-year to -$1.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$5.3 million (down 836.11% YoY) and the FY2026 annual result came in at -$4.6 million, down 179.58% from the prior year.
- Cash from Financing Activities declined to -$1.7 million in Q2 2026, from -$50000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $7.1 million in Q3 2023 to a low of -$4.5 million in Q2 2025.
- A 5-year average of $893411.8 and a median of $367000.0 in 2023 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities soared 398.02% — and 2025, when it plunged 2885.28%.
- Tracing STAA's Cash from Financing Activities over 5 years: stood at $202000.0 in 2022, then surged by 81.68% to $367000.0 in 2023, then plunged by 129.97% to -$110000.0 in 2024, then surged by 993.64% to $983000.0 in 2025, then sank by 272.23% to -$1.7 million in 2026.
- The last three Cash from Financing Activities figures came in at -$1.7 million (Q2 2026), -$50000.0 (Q1 2026), and $983000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Staar Surgical | 1.16 Bn | 978.41 Mn | 69.73 Mn | -1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | -1.50 Mn |
| Jul 3, 2026 | -1.50 Mn |
| Apr 3, 2026 | -1.69 Mn |
| Apr 3, 2026 | -1.69 Mn |
| Jan 2, 2026 | -50,000.00 |
| Jan 2, 2026 | -50,000.00 |
| Sep 26, 2025 | 983,000.00 |
| Sep 26, 2025 | 983,000.00 |
| Jun 27, 2025 | -4.54 Mn |
| Jun 27, 2025 | -4.54 Mn |
| Mar 28, 2025 | -948,000.00 |
| Mar 28, 2025 | -948,000.00 |
| Dec 27, 2024 | -110,000.00 |
| Dec 27, 2024 | -110,000.00 |
| Sep 27, 2024 | 1.62 Mn |
| Sep 27, 2024 | 1.62 Mn |
| Jun 28, 2024 | 163,000.00 |
| Jun 28, 2024 | 163,000.00 |
| Mar 29, 2024 | 4.06 Mn |
| Mar 29, 2024 | 4.06 Mn |